Soligenix
SNGX
$0.32
Share price
-10.00%
Change (1 day)
-56.25%
Change (1 year)
Categories
Soligenix (SNGX) - Total debt
Total debt on the balance sheet as of March 2024 : $3.2 M
According to Soligenix's latest financial reports the company's total debt is $3.2 M. A company’s total debt is the sum of all current and non-current debts.
Soligenix - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $10.24 M | 2.79% |
| 2021-12-31 | $9.96 M | -5.18% |
| 2020-12-31 | $10.5 M | 8158% |
| 2019-12-31 | $0.12 M | |
| 2018-12-31 | $N/A | |
| 2016-12-31 | $N/A | -100% |
| 2015-12-31 | $0.29 M | -92.28% |
| 2014-12-31 | $3.78 M | -54.24% |
| 2013-12-31 | $8.28 M | |
| 2004-12-31 | $0.11 M | -67.71% |
| 2003-12-31 | $0.35 M | -50.81% |
| 2002-12-31 | $0.72 M | 236.63% |
| 2001-12-31 | $0.21 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 1,050,768.64% | 🇺🇸 USA |
 Pfizer PFE | $68.70 B | 2,146,756.64% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 636,292.33% | 🇫🇷 France |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |
 Athersys ATHX | $18.57 M | 480.46% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $19.93 B | 622,884.63% | 🇮🇱 Israel |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.90 B | 28,205.84% | 🇺🇸 USA |